Simplex Trading
IMNM icon

Simplex Trading’s Immunome IMNM Stock Holding History

Simplex Trading’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$446K Sell
20,400
-16,800
-45% -$374K ﹤0.01% 3404
2025
Q4 		$799K Buy
37,200
+26,400
+244% +$463K ﹤0.01% 2842
2025
Q3 		$126K Buy
10,800
+4,300
+66% +$42.8K ﹤0.01% 5486
2025
Q2 		$60K Sell
6,500
-800
-11% -$6.56K ﹤0.01% 5743
2025
Q1 		$49K Sell
7,300
-4,000
-35% -$38.4K ﹤0.01% 5789
2024
Q4 		$120K Buy
11,300
+8,400
+290% +$102K ﹤0.01% 5012
2024
Q3 		$42K Sell
2,900
-3,900
-57% -$55.4K ﹤0.01% 6037
2024
Q2 		$82K Buy
6,800
+6,200
+1,033% +$97K ﹤0.01% 5576
2024
Q1 		$14K Buy
+600
New +$12.2K ﹤0.01% 7374
2023
Q4 		– Sell
-400
Closed -$3K – 9288
2023
Q3 		$3K Sell
400
-3,700
-90% -$27.2K ﹤0.01% 7900
2023
Q2 		$32K Sell
4,100
-3,500
-46% -$19.1K ﹤0.01% 6293
2023
Q1 		$37K Buy
7,600
+4,500
+145% +$22K ﹤0.01% 6257
2022
Q4 		$6K Buy
+3,100
New +$12.5K ﹤0.01% 7931
2022
Q1 		– Sell
-1,200
Closed -$15K – 10858
2021
Q4 		$15K Buy
1,200
+900
+300% +$16.1K ﹤0.01% 8683
2021
Q3 		$5K Hold
300
– – ﹤0.01% 9269
2021
Q2 		$5K Buy
+300
New +$6.63K ﹤0.01% 9453

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Simplex Trading's IMNM Position: Q1 2026 in Review

Simplex Trading sold out of Immunome (IMNM) in Q1 2026, closing a stake of 23,401 shares — an estimated $521K sold.

Simplex Trading first reported a position in IMNM in Q2 2021 and held it in 17 quarters. The position peaked at $722K in Q3 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Simplex Trading reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 23,401 Immunome shares in Q1 2026, an estimated $521K.
  • Simplex Trading first reported a position in Immunome in Q2 2021 and held it in 17 quarters.
  • Simplex Trading's Immunome position peaked at $722K in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.